BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28867113)

  • 1. Precision Medicine and PET-Computed Tomography in Pediatric Malignancies.
    Sanli Y; Yilmaz E; Subramaniam RM
    PET Clin; 2017 Oct; 12(4):423-435. PubMed ID: 28867113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/Computed Tomography and Precision Medicine: Musculoskeletal Sarcoma.
    Kandathil A; Subramaniam RM
    PET Clin; 2017 Oct; 12(4):475-488. PubMed ID: 28867117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
    Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
    J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET/CT in pediatric solid tumors.
    Franzius C
    Q J Nucl Med Mol Imaging; 2010 Aug; 54(4):401-10. PubMed ID: 20823808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/Computed Tomography Scanning and Precision Medicine: Esophageal Cancer.
    Goel R; Subramaniam RM; Wachsmann JW
    PET Clin; 2017 Oct; 12(4):373-391. PubMed ID: 28867110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
    Dhull VS; Sharma P; Patel C; Kundu P; Agarwala S; Bakhshi S; Bhatnagar V; Bal C; Kumar R
    Nucl Med Commun; 2015 Oct; 36(10):1007-13. PubMed ID: 26049371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of
    Harrison DJ; Parisi MT; Shulkin BL
    Semin Nucl Med; 2017 May; 47(3):229-241. PubMed ID: 28417853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
    Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
    Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies.
    Uslu L; Donig J; Link M; Rosenberg J; Quon A; Daldrup-Link HE
    J Nucl Med; 2015 Feb; 56(2):274-86. PubMed ID: 25572088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear Medicine in Pediatric and Adolescent Tumors.
    Kiratli PÖ; Tuncel M; Bar-Sever Z
    Semin Nucl Med; 2016 Jul; 46(4):308-23. PubMed ID: 27237441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET with
    Harrison DJ; Parisi MT; Khalatbari H; Shulkin BL
    PET Clin; 2020 Jul; 15(3):333-347. PubMed ID: 32498989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
    Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
    J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
    Völker T; Denecke T; Steffen I; Misch D; Schönberger S; Plotkin M; Ruf J; Furth C; Stöver B; Hautzel H; Henze G; Amthauer H
    J Clin Oncol; 2007 Dec; 25(34):5435-41. PubMed ID: 18048826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
    Kushner BH; Yeung HW; Larson SM; Kramer K; Cheung NK
    J Clin Oncol; 2001 Jul; 19(14):3397-405. PubMed ID: 11454888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical impact of
    Hart A; Vali R; Marie E; Shaikh F; Shammas A
    Pediatr Radiol; 2017 Oct; 47(11):1508-1513. PubMed ID: 28664453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of clinical impact of
    Liu J; Larcos G; Howle J; Veness M
    Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/Computed Tomography and Precision Medicine: Gastric Cancer.
    Marcus C; Subramaniam RM
    PET Clin; 2017 Oct; 12(4):437-447. PubMed ID: 28867114
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Chambers G; Frood R; Patel C; Scarsbrook A
    Br J Radiol; 2019 Feb; 92(1094):20180584. PubMed ID: 30383441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.